Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Demetriou

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Nature Communications|June 2, 2011
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosisHaik Mkhikian, Ani Grigorian, Carey F Li, et al.
Nature Aging|May 9, 2022
Age-associated impairment of T cell immunity is linked to sex-dimorphic elevation of N-glycan branchingHaik Mkhikian, Ken L Hayama, Khachik Khachikyan, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Nature Communications|June 2, 2011
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosisHaik Mkhikian, Ani Grigorian, Carey F Li, et al.
Nature Aging|May 9, 2022
Age-associated impairment of T cell immunity is linked to sex-dimorphic elevation of N-glycan branchingHaik Mkhikian, Ken L Hayama, Khachik Khachikyan, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Pageof 5